April 6, 2012 — St. Jude Medical Inc. announced it has appointed Population Health Research Institute (PHRI), an academic health science research institute, to analyze data from three combined registries on the Riata ST Optim and Durata implantable cardioverter defibrillator (ICD) leads. The analysis will be entirely under the control of PHRI, who will complete a review of the performance of the leads.

April 6, 2012 — The U.S. anticoagulant market is on the verge of a major shift in clinical practice, transitioning from a market dominated by a single injectable anticoagulant to a highly competitive one dominated by first-in-class novel oral anticoagulants. Companies are vying with each other to introduce novel therapies that offer superior safety, efficacy and convenience to patients and physicians.

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical manufacturing facility in Crown Point, Ind.

April 6, 2012 — AliveCor, developer of the mobile electrocardiogram (ECG) recorder, announced results from a study that demonstrated how the company’s ECG monitoring device is intuitive and allows users to learn and characterize their heart rates by using the hand-held device in their hands or on their chest. The data from the credit-card-sized wireless device is designed to help physicians and health care providers monitor and assess their patients’ heart health for a variety of medical reasons.

April 6, 2012 — Boston Scientific Corp. announced results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM randomized clinical trials, comprising more than 2,400 patients across three distinct coronary stent platforms:  the Platinum Chromium Element platform (Ion Paclitaxel-Eluting Stent System [Taxus Element] and Promus Element Everolimus-Eluting Stent System), the Xience V Promus Everolimus-Eluting Stent System, and the Taxus Express Paclitaxel-Eluting Stent System.

April 6, 2012 — St. Jude Medical announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite and QuickFlex left ventricular (LV) leads, used to connect cardiac resynchronization therapy (CRT) devices to the heart.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now